https://www.selleckchem.com/products/tbopp.html
Five children and 11 adults were enrolled in the study. After one year, the group treated with cidofovir had a significant decrease in Derkay score (p=.027). No difference between treatment arms was observed in the annual surgery rate. There was a significant decrease in the VHI score in all treatment groups (p.001), and no significant difference was observed between groups (p=.32). While we observed a significant decrease in RRP severity with intralesional cidofovir, we were unable to provide proof of efficacy of intralesional bevaci
Curtir
Comentario
Compartilhar
